623 related items for PubMed ID: 30180402
1. [Mycophenolate mofetil versus cyclosporine A in children with primary refractory nephrotic syndrome].
Geng HY, Ji LN, Chen CY, Tu J, Li HR, Bao R, Lin Y.
Zhonghua Er Ke Za Zhi; 2018 Sep 02; 56(9):651-656. PubMed ID: 30180402
[Abstract] [Full Text] [Related]
2. Study protocol: mycophenolate mofetil as maintenance therapy after rituximab treatment for childhood-onset, complicated, frequently-relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicenter double-blind, randomized, placebo-controlled trial (JSKDC07).
Horinouchi T, Sako M, Nakanishi K, Ishikura K, Ito S, Nakamura H, Oba MS, Nozu K, Iijima K.
BMC Nephrol; 2018 Nov 01; 19(1):302. PubMed ID: 30382824
[Abstract] [Full Text] [Related]
3. Mycophenolate mofetil therapy for children with intractable nephrotic syndrome.
Okada M, Sugimoto K, Yagi K, Yanagida H, Tabata N, Takemura T.
Pediatr Int; 2007 Dec 01; 49(6):933-7. PubMed ID: 18045300
[Abstract] [Full Text] [Related]
4. Mycophenolate mofetil in steroid/cyclosporine-dependent/resistant nephrotic syndrome.
Mendizábal S, Zamora I, Berbel O, Sanahuja MJ, Fuentes J, Simon J.
Pediatr Nephrol; 2005 Jul 01; 20(7):914-9. PubMed ID: 15891923
[Abstract] [Full Text] [Related]
5. Evaluation of mycophenolate mofetil or tacrolimus in children with steroid sensitive but frequently relapsing or steroid-dependent nephrotic syndrome.
Wang J, Mao J, Chen J, Fu H, Shen H, Zhu X, Liu A, Shu Q, Du L.
Nephrology (Carlton); 2016 Jan 01; 21(1):21-7. PubMed ID: 26697959
[Abstract] [Full Text] [Related]
6. [Mycophenolate mofetil in treatment of childhood nephrotic syndrome--preliminary report].
Kwinta-Rybicka J, Wilkosz K, Wierzchowska-Słowiacze EK, Ogarek I, Moczulska A, Stec Z, Pełkowska A, Sancewicz-Pach K, Pietrzyk JA.
Przegl Lek; 2006 Jan 01; 63 Suppl 3():44-8. PubMed ID: 16898486
[Abstract] [Full Text] [Related]
7. Three year outcome of childhood idiopathic nephrotic syndrome under a unified immunosuppressive protocol.
Hibino S, Uemura O, Nagai T, Yamakawa S, Iwata N, Ito H, Nakano M, Tanaka K.
Pediatr Int; 2015 Jan 01; 57(1):85-91. PubMed ID: 25225083
[Abstract] [Full Text] [Related]
8. [Mycophenolate mofetil in the treatment of primary nephrotic syndrome].
Zhao M, Chen X, Chen Y, Liu Z, Liu Y, Lu F, Zhang Y, Wang H.
Zhonghua Yi Xue Za Zhi; 2001 May 10; 81(9):528-31. PubMed ID: 11809115
[Abstract] [Full Text] [Related]
9. Long-term outcome of Japanese children with complicated minimal change nephrotic syndrome treated with mycophenolate mofetil after cyclosporine.
Fujinaga S, Hirano D, Nishino T, Umeda C, Watanabe Y, Nakagawa M.
Pediatr Nephrol; 2019 Nov 10; 34(11):2417-2421. PubMed ID: 31435725
[Abstract] [Full Text] [Related]
10. Sequential maintenance therapy with cyclosporin A and mycophenolate mofetil for sustained remission of childhood steroid-resistant nephrotic syndrome.
Gellermann J, Ehrich JH, Querfeld U.
Nephrol Dial Transplant; 2012 May 10; 27(5):1970-8. PubMed ID: 21976740
[Abstract] [Full Text] [Related]
11. Idiopathic nephrotic syndrome in Syrian children: clinicopathological spectrum, treatment, and outcomes.
Wannous H.
Pediatr Nephrol; 2024 Aug 10; 39(8):2413-2422. PubMed ID: 38587559
[Abstract] [Full Text] [Related]
12. Efficacy of mycophenolate mofetil in pediatric patients with steroid-dependent nephrotic syndrome.
Novak I, Frank R, Vento S, Vergara M, Gauthier B, Trachtman H.
Pediatr Nephrol; 2005 Sep 10; 20(9):1265-8. PubMed ID: 15942779
[Abstract] [Full Text] [Related]
13. Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
Hodson EM, Wong SC, Willis NS, Craig JC.
Cochrane Database Syst Rev; 2016 Oct 11; 10(10):CD003594. PubMed ID: 27726125
[Abstract] [Full Text] [Related]
14. Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome.
Bagga A, Hari P, Moudgil A, Jordan SC.
Am J Kidney Dis; 2003 Dec 11; 42(6):1114-20. PubMed ID: 14655181
[Abstract] [Full Text] [Related]
15. Mycophenolate mofetil therapy for steroid-resistant IgA nephropathy with the nephrotic syndrome in children.
Kang Z, Li Z, Duan C, Wu T, Xun M, Ding Y, Zhang Y, Zhang L, Yin Y.
Pediatr Nephrol; 2015 Jul 11; 30(7):1121-9. PubMed ID: 25773534
[Abstract] [Full Text] [Related]
16. A comparison of a standard-dose prednisone regimen and mycophenolate mofetil combined with a lower prednisone dose in Chinese adults with idiopathic nephrotic syndrome who were carriers of hepatitis B surface antigen: a prospective cohort study.
Li X, Tian J, Wu J, He Q, Li H, Han F, Li Q, Chen Y, Ni Q, Chen J.
Clin Ther; 2009 Apr 11; 31(4):741-50. PubMed ID: 19446147
[Abstract] [Full Text] [Related]
17. Initial treatment of steroid-sensitive idiopathic nephrotic syndrome in children with mycophenolate mofetil versus prednisone: protocol for a randomised, controlled, multicentre trial (INTENT study).
Ehren R, Benz MR, Doetsch J, Fichtner A, Gellermann J, Haffner D, Höcker B, Hoyer PF, Kästner B, Kemper MJ, Konrad M, Luntz S, Querfeld U, Sander A, Toenshoff B, Weber LT, Gesellschaft für Pädiatrische Nephrologie (GPN).
BMJ Open; 2018 Oct 10; 8(10):e024882. PubMed ID: 30309995
[Abstract] [Full Text] [Related]
18. [Mycophenolate mofetil restores renal function and spares steroids during idiopathic nephrotic syndrome in children. A cohort study].
Cailliez M, Bruno D, Daniel L, Afaneti M, Bérard E, Sarles J, Tsimaratos M.
Nephrol Ther; 2008 Feb 10; 4(1):15-20. PubMed ID: 18096455
[Abstract] [Full Text] [Related]
19. Mycophenolate mofetil is inferior to tacrolimus in sustaining remission in children with idiopathic steroid-resistant nephrotic syndrome.
Sinha A, Gupta A, Kalaivani M, Hari P, Dinda AK, Bagga A.
Kidney Int; 2017 Jul 10; 92(1):248-257. PubMed ID: 28318625
[Abstract] [Full Text] [Related]
20. Novel multidrug therapy for children with cyclosporine-resistant or -intolerant nephrotic syndrome.
Aizawa-Yashiro T, Tsuruga K, Watanabe S, Oki E, Ito E, Tanaka H.
Pediatr Nephrol; 2011 Aug 10; 26(8):1255-61. PubMed ID: 21479767
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
